Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661048 · ClinicalTrials.gov registry record · NA
CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation
A NA study of Tachycardia, Ventricular, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT02661048 is a NA study of Tachycardia, Ventricular that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 5 participants, below the 300-participant average among 4 other Tachycardia, Ventricular trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02661048, a NA study of Tachycardia, Ventricular, has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this clinical investigation is to evaluate: 1. the safety and efficacy of the CyberHeart System, CardioPlan™ Software and Laptop, in treating patients with refractory ventricular tachycardia (VT) using the CyberKnife® Radiosurgical System. 2. The CyberHeart System performance with respect to the ability to contour myocardial targets that are transferred to the Multi-plan® Treatment Planning Software of the CyberKnife® system for the production and delivery of a safe radiosurgical treatment plan. Cardiac radiosurgery is a minimally-non invasive, painless, procedure. Tissue ablation can be accomplished precisely.
Conditions Studied
Interventions
- DEVICE CyberHeart System
Study Locations (1)
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-02-27 |
| Est. Completion | 2023-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661048
The ClinicalTrials.gov registry entry for NCT02661048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 4 other Tachycardia, Ventricular trials with a reported enrollment target (98% lower). The listed sponsor is Varian, a Siemens Healthineers Company, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tachycardia, Ventricular appearing as the primary indexed condition, and to 1 intervention - of which CyberHeart System is the first listed.
NCT02661048 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02661048 about?
NCT02661048 is a clinical study titled "CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation". The objective of this clinical investigation is to evaluate: 1. the safety and efficacy of the CyberHeart System, CardioPlan™ Software and Laptop, in treating patients with refractory ventricular tachycardia (VT) using the CyberKnife® Radiosurgical System. 2. The CyberHeart System performance with ...
What is the current status of trial NCT02661048?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-02-27. Estimated completion is 2023-07-06.
What conditions does trial NCT02661048 study?
This clinical trial studies the following conditions: Tachycardia, Ventricular.
What interventions are being tested in trial NCT02661048?
The interventions under investigation include: CyberHeart System (DEVICE).
Who is sponsoring clinical trial NCT02661048?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02661048 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia, Ventricular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
RECRUITING · NA
-
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
ACTIVE NOT RECRUITING · NA
-
S-ICD® System IDE Clinical Study
COMPLETED · NA
-
Automatic External Defibrillation Monitoring in Cardiac Arrest
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.